Pharmacological Interventions Targeting Pain in Fibrous Dysplasia/McCune–Albright Syndrome
International Journal of Molecular Sciences · 29.01.2023 · 24 (3) · 2550
DOI: 10.3390/ijms24032550 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 29.01.2023. Verfasst von Anthony Tucker-Bartley und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Anesthesiology, Critical Care and Pain Medicine, Boston Children's Hospital, Harvard Medical School, Boston, MA 02115, USA. Hauptthemen laut MEDLINE: Fibrous Dysplasia, Polyostotic, Endocrine System Diseases, Musculoskeletal Pain. Die Arbeit wurde bisher 25-mal zitiert (Crossref) und nennt 100 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Mayday Fund.
Abstract (Originalsprache)
Fibrous dysplasia (FD) is a rare, non-inherited bone disease occurring following a somatic gain-of-function R201 missense mutation of the guanine-nucleotide binding protein alpha subunit stimulating activity polypeptide 1 (GNAS) gene. The spectrum of the disease ranges from a single FD lesion to a combination with extraskeletal features; an amalgamation with café-au-lait skin hyperpigmentation, precocious puberty, and other endocrinopathies defines McCune–Albright Syndrome (MAS). Pain in FD/MAS represents one of the most prominent aspects of the disease and one of the most challenging to treat—an outcome driven by (i) the heterogeneous nature of FD/MAS, (ii) the variable presentation of pain phenotypes (i.e., craniofacial vs. musculoskeletal pain), (iii) a lack of studies probing pain mechanisms, and (iv) a lack of rigorously validated analgesic strategies in FD/MAS. At present, a range of pharmacotherapies are prescribed to patients with FD/MAS to mitigate skeletal disease activity, as well as pain. We analyze evidence guiding the current use of bisphosphonates, denosumab, and other therapies in FD/MAS, and also discuss the potential underlying pharmacological mechanisms by which pain relief may be achieved. Furthermore, we highlight the range of presentation of pain in individual cases of FD/MAS to further describe the difficulties associated with employing effective pain treatment in FD/MAS. Potential next steps toward identifying and validating effective pain treatments in FD/MAS are discussed, such as employing randomized control trials and probing new pain pathways in this rare bone disease.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Anesthesiology, Critical Care and Pain Medicine, Boston Children's Hospital, Harvard Medical School, Boston, MA 02115, USA.
- Department of Anesthesiology, Critical Care and Pain Medicine, Massachusetts General Hospital, Harvard Medical School, Boston, MA 02114, USA.
- Division of Endocrinology, Department of Medicine, Warren Alpert Medical School of Brown University, Providence, RI 02903, USA.
- Department of Pediatric Hematology Oncology, Massachusetts General Hospital, Harvard Medical School, Boston, MA 02115, USA.
- Endocrine Unit, Massachusetts General Hospital, Harvard Medical School, Boston, MA 02115, USA.
- Department of Psychiatry, McLean Hospital, Harvard Medical School, Belmont, MA 02478, USA.
ORCID-Profile: Anthony Tucker-Bartley, Daryl J Selen, Raquel van Gool
Förderung
- Mayday Fund
Zitieren
APA
Tucker-Bartley, A., Selen, D. J., Golden, E., van Gool, R., Ebb, D., Mannstadt, M., & Upadhyay, J. (2023). Pharmacological Interventions Targeting Pain in Fibrous Dysplasia/McCune–Albright Syndrome. International Journal of Molecular Sciences, 24(3), 2550. https://doi.org/10.3390/ijms24032550
Vancouver
Tucker-Bartley A, Selen DJ, Golden E, van Gool R, Ebb D, Mannstadt M, et al. Pharmacological Interventions Targeting Pain in Fibrous Dysplasia/McCune–Albright Syndrome. International Journal of Molecular Sciences. 2023;24(3):2550. doi:10.3390/ijms24032550
BibTeX
@article{TuckerBartley2023,
author = {Tucker-Bartley, Anthony and Selen, Daryl J and Golden, Emma and van Gool, Raquel and Ebb, David and Mannstadt, Michael and Upadhyay, Jaymin},
title = {Pharmacological Interventions Targeting Pain in Fibrous Dysplasia/McCune–Albright Syndrome},
journal = {International Journal of Molecular Sciences},
year = {2023},
volume = {24},
number = {3},
pages = {2550},
doi = {10.3390/ijms24032550}
}
EUVIMED